http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-301740-A7

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da9c519bc5d52cdf9e2c478e123d9f7b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-00
filingDate 1990-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1993-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-301740-A7
titleOfInvention Method for the microbial degradation of sterols to ndrosta-1,4-diene-3,17-dione
abstract The invention relates to an improved process for the microbial degradation of sterols to androsta-1,4-diene-3,17-dione (ADD) by degradation of the side chain. The compound ADD is known as an intermediate of sterol degradation and serves as a key product for the production of a range of steroid drugs. The object of the invention to initially produce ADD crude products with high analytical product formation rates and high molar yields whose AD by-product content is so low that ADD of high purity is obtained by simple preparative workup, is achieved in that for a microorganism of the species Mycobacterium vaccae a defined management of the seed culture is used, which is accompanied by a specific alkalization as metrologically detectable parameter. After fermentation of the main culture in a manner known per se and after separation of other accompanying substances, the target product ADD is then obtained in high purity by simple work-up (crystallization). {Microbial degradation of sterols; Microorganism Mycobacterium vaccae; defined management of the seed culture; Major product androsta-1,4-diene-3,17-dione (ADD); high product formation rate; low androst-4-ene-3,17-dione fraction (AD)}
priorityDate 1990-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444679
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154495922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7294
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6128
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6454094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407604914
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426111745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321421

Total number of triples: 41.